New Indications for Ultrasound in the Staging of Cervical Cancer

NCT ID: NCT00451945

Last Updated: 2008-06-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2007-03-31

Study Completion Date

2008-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose is to investigate and evaluate two new diagnostic methods using ultrasound in the staging of cervical cancer.

1. 3-D-ultrasound of the tumour to estimate its volume and local spread
2. Fusion of PET/CT and ultrasound to evaluate and biopsy lymph nodes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cervical Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

SINGLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

biopsy

Intervention Type PROCEDURE

3d-ultrasound and fusion of UL and PET/CT

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Cervical cancer,
* PET/CT pos. lymph nodes,
* Patients over 18 years old

Exclusion Criteria

* Pregnancy,
* Lactating,
* Diabetic
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rigshospitalet, Denmark

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael B Nielsen, MDSc

Role: PRINCIPAL_INVESTIGATOR

Department of radiology, section of ultrasound

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Copenhagen univercity hospital, Department of Radiology, section of ultrasound

Copenhagen, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H-KF 2007-004

Identifier Type: -

Identifier Source: org_study_id